logo
logo

Cure Lab Oncology Names Dr. Aubrey C. Galloway As Chief Medical Officer

Jul 11, 2024•about 1 year ago

Position

Chief Medical Officer

Company

Curelab Oncology

Aubrey C. Galloway
DedhamBiotechnology

Description

CureLab Oncology has appointed Dr Aubrey C Galloway as chief medical officer, a strategic move following his recent addition to the company's scientific advisory board. Dr Galloway, a renowned cardiac surgeon and the Seymour Cohn Professor of Cardiothoracic Surgery at NYU Langone Health, brings extensive expertise in clinical trials, cardiovascular disease research, and an understanding of host inflammatory mediators of a variety of inflammatory diseases to this new position at CureLab Oncology.

Company Information

Company

Curelab Oncology

Location

417 GREENLODGE STREET

Dedham, Iowa, United States

About

CureLab Oncology Inc. is a clinical-stage biotech company headquartered in the greater Boston area, Massachusetts. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab's lead investigational compound is code-named Elenagen, an experimental DNA therapy that consists of a circular piece of DNA called a plasmid that includes a gene for a human protein called p62/SQSTM1.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months